Patents by Inventor Dirk Bartnik

Dirk Bartnik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • D-enantiomeric peptides derived from D3 and use thereof
    Patent number: 10889618
    Abstract: The present invention relates to novel D-enantiomeric A-beta-oligomer-binding peptides, homologs, fragments, parts and polymers thereof and use thereof.
    Type: Grant
    Filed: November 27, 2018
    Date of Patent: January 12, 2021
    Assignee: FORSCHUNGSZENTRUM JUELICH GMBH
    Inventors: Dieter Willbold, Susanne Aileen Funke, Oleksander Brener, Luitgard Nagel-Steger, Dirk Bartnik, Antonia Nicole Klein
  • NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND USE THEREOF
    Publication number: 20190085030
    Abstract: The present invention relates to novel D-enantiomeric A-beta-oligomer-binding peptides, homologs, fragments, parts and polymers thereof and use thereof.
    Type: Application
    Filed: November 27, 2018
    Publication date: March 21, 2019
    Inventors: Dieter Willbold, Susanne Aileen Funke, Oleksander Brener, Luitgard Nagel-Steger, Dirk Bartnik, Antonia Nicole Klein
  • D-enantiomeric peptides derived from D3 and use thereof
    Patent number: 10167318
    Abstract: The present invention relates to novel D-enantiomeric A-beta-oligomer-binding peptides, homologs, fragments, parts and polymers thereof and use thereof.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: January 1, 2019
    Assignee: FORSCHUNGSZENTRUM JUELICH GMBH
    Inventors: Dieter Willbold, Susanne Aileen Funke, Oleksander Brener, Luitgard Nagel-Steger, Dirk Bartnik, Antonia Nicole Klein
  • NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND USE THEREOF
    Publication number: 20170313744
    Abstract: The present invention relates to novel D-enantiomeric A-beta-oligomer-binding peptides, homologs, fragments, parts and polymers thereof and use thereof.
    Type: Application
    Filed: April 10, 2017
    Publication date: November 2, 2017
    Inventors: Dieter WILLBOLD, Susanne Aileen FUNKE, Oleksander BRENER, Luitgard NAGEL-STEGER, Dirk BARTNIK, Antonia Nicole KLEIN
  • Peptides that bind to amino-truncated amyloid-beta-peptide and use of said peptides
    Patent number: 9611296
    Abstract: Peptides that bind to amino-terminal truncated pEA?3-42, the free glutamic acid residue of which lies in position 3 or 11 in the form of cyclized pyroglutamate. Four oligopeptides were identified using mirror image phage display technology.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: April 4, 2017
    Assignee: Forschungszentrum Juelich GmbH
    Inventors: Dieter Willbold, Susanne Aileen Funke, Yeliz Cinar, Dirk Bartnik, Hans-Ulrich Demuth, Martin Kleinschmidt, Hans-Henning Ludwig
  • POLYMERS CONTAINING MULTIVALENT AMYLOID-BETA-BINDING D-PEPTIDES AND THEIR USE
    Publication number: 20160376335
    Abstract: The invention relates to novel multivalent polymeric amyloid-beta-binding substances composed of several interconnected substances which per se already have amyloid-beta-binding properties, and to the use of these substances, referred to hereinbelow as “polymers”, in particular in medicine.
    Type: Application
    Filed: September 13, 2016
    Publication date: December 29, 2016
    Inventors: Dieter WILLBOLD, Susanne Aileen FUNKE, Oleksander BRENER, Luitgard NAGEL-STEGER, Dirk BARTNIK
  • Polymers containing multivalent amyloid-beta-binding D-peptides and their use
    Patent number: 9464118
    Abstract: The invention relates to novel multivalent polymeric amyloid-beta-binding substances composed of several interconnected substances which per se already have amyloid-beta-binding properties, and to the use of these substances, referred to hereinbelow as “polymers”, in particular in medicine.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: October 11, 2016
    Assignee: FORSCHUNGSZENTRUM JUELICH GMBH
    Inventors: Dieter Willbold, Susanne Aileen Funke, Oleksander Brener, Luitgard Nagel-Steger, Dirk Bartnik
  • NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND USE THEREOF
    Publication number: 20150307552
    Abstract: The present invention relates to novel D-enantiomeric A-beta-oligomer-binding peptides, homologs, fragments, parts and polymers thereof and use thereof.
    Type: Application
    Filed: September 13, 2013
    Publication date: October 29, 2015
    Inventors: Dieter WILLBOLD, Susanne Aileen FUNKE, Oleksander BRENER, Luitgard NAGEL-STEGER, Dirk BARTNIK, Antonia Nicole KLEIN
  • PEPTIDES THAT BIND TO AMINO-TRUNCATED AMYLOID-BETA-PEPTIDE AND USE OF SAID PEPTIDES
    Publication number: 20150284432
    Abstract: Peptides that bind to amino-terminal truncated pEA?3-42, the free glutamic acid residue of which lies in position 3 or 11 in the form of cyclized pyroglutamate. Four oligopeptides were identified using mirror image phage display technology.
    Type: Application
    Filed: September 25, 2013
    Publication date: October 8, 2015
    Inventors: Dieter Willbold, Susanne Aileen Funke, Yeliz Cinar, Dirk Bartnik, Hans-Ulrich Demuth, Martin Kleinschmidt, Hans-Henning Ludwig
  • POLYMERS CONTAINING MULTIVALENT AMYLOID-BETA-BINDING D-PEPTIDES AND THEIR USE
    Publication number: 20150119336
    Abstract: The invention relates to novel multivalent polymeric amyloid-beta-binding substances composed of several interconnected substances which per se already have amyloid-beta-binding properties, and to the use of these substances, referred to hereinbelow as “polymers”, in particular in medicine.
    Type: Application
    Filed: April 5, 2013
    Publication date: April 30, 2015
    Inventors: Dieter Willbold, Susanne Aileen Funke, Oleksander Brener, Luitgard Nagel-Steger, Dirk Bartnik
  • AGENTS FOR TREATING ALZHEIMER'S DISEASE
    Publication number: 20130143822
    Abstract: Agents for treating Alzheimer's disease comprising a peptide according to sequence no. 1 which binds to A? oligomers and thus results in the healing or alleviation of Alzheimer's disease. In further embodiments peptides are provided which contain a sequence no. 1, but have preceding sequence sections which allow the peptide to be secreted. For the purpose of gene therapy, corresponding DNA sequences and vectors, in particular according to sequences 3 to 6, are provided.
    Type: Application
    Filed: April 9, 2011
    Publication date: June 6, 2013
    Inventors: Susanne Aileen Funke, Luitgard Nagel-Steger, Dirk Bartnik, Olexandr Brener, Torsten Sehl, Katja Wiesehan, Dieter Willbold